Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01949623 · ClinicalTrials.gov registry record
Biomarkers In Retinitis Pigmentosa (BIRP)
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 100
- Enrollment target
NCT01949623: Completed study, sponsored by Johns Hopkins University.
NCT01949623 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01949623 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
In this study, markers of oxidative stress will be measured in the aqueous humour and plasma of RP patients compared to controls.
Interventions
- OTHER Anterior Chamber (AC) tap
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2013-09 |
| Est. Completion | 2017-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01949623
The ClinicalTrials.gov registry entry for NCT01949623 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Anterior Chamber (AC) tap is the first listed.
NCT01949623 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01949623 about?
NCT01949623 is a clinical study titled "Biomarkers In Retinitis Pigmentosa (BIRP)". In this study, markers of oxidative stress will be measured in the aqueous humour and plasma of RP patients compared to controls.
What is the current status of trial NCT01949623?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2013-09. Estimated completion is 2017-07.
What interventions are being tested in trial NCT01949623?
The interventions under investigation include: Anterior Chamber (AC) tap (OTHER).
Who is sponsoring clinical trial NCT01949623?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.